Skip to main content

Table 1 Basic characteristics of included studies in the systematic review

From: Clinical efficacy of enhanced recovery after surgery (ERAS) program in patients undergoing radical prostatectomy: a systematic review and meta-analysis

Author

Country

Design

ERAS group/control group

Operation

Age (year)

PSA (ng/ml)

BMI

ERAS group

Control group

ERAS group

Control group

ERAS group

Control group

Magheli et al. [12]

Germany

RCT

25/25

LRP

61.8 ± 4.7

61.9 ± 7

7.2 ± 4.9

10.3 ± 8.6

/

/

Ren et al. [15]

China

RCT

9/9

LRP

69.2

12

/

/

Huang et al. [10]

China

Retrospective cohort study

36/37

RALP

62.1 ± 6.9

63.5 ± 7.4

13.44 ± 8.01

15.4 ± 10.59

23.1 ± 2.1

23.5 ± 2.2

Pan and Li [14]

China

RCT

50/50

LRP

69.3 ± 7.32

/

/

/

/

Yu and Wang [16]

China

RCT

26/25

RALP

67.65 ± 7.37

72.00 ± 6.07

31.55 ± 22.57

31.35 ± 31.46

21.88 ± 2.49

20.84 ± 3.15

Dong et al. [13]

China

RCT

109/95

RALP/LRP

66.76 ± 5.83

66.95 ± 5.70

/

/

22.39±1.47

22.32 ± 1.54

Lin et al. [11]

China

Retrospective cohort study

124/164

LRP

70.9 ± 3.6

70 ± 4.3

44.5 ± 22.3

36.8 ± 23.2

20.3 ± 1.5

20.4 ± 1.4

  1. RCT randomized controlled trial, LRP laparoscopic radical prostatectomy, RALP robot-assisted laparoscopic prostatectomy, PSA prostate specific antigen, BMI body mass index